A case series of live attenuated vaccine administration in dupilumab‐treated children with atopic dermatitis

Documenti analoghi

• Dupilumab treatment in children aged 6 months to 5 years with severe atopic dermatitis
  di: Audrey Lasek, et al.
  Pubblicazione: (2025)
• Residual facial erythema in atopic dermatitis patients treated with dupilumab stratified by machine learning
  di: Koichi Ashizaki, et al.
  Pubblicazione: (2024)
• Severe atopic dermatitis in an Asian‐Arabic population treated with dupilumab: A retrospective observational study
  di: Radi Al Chalabi, et al.
  Pubblicazione: (2024)
• Pregnancy and breastfeeding outcome in patients with atopic dermatitis treated with dupilumab: the clinical experience of three centers
  di: Joana Xará, et al.
  Pubblicazione: (2024)
• Bridging the gap: Treatment of atopic dermatitis with dupilumab during pregnancy
  di: Christian Vestergaard, et al.
  Pubblicazione: (2025)